Cargando…
Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer
Cancer is a leading cause of death worldwide. Cervical cancer caused by human papillomavirus (HPV) is a major health problem in women. DNA vaccines are a perfect approach to immunization, but their potency in clinical trials has been insufficient for generating effective immunity, which may be relat...
Autores principales: | Karimi, Hesam, Soleimanjahi, Hoorieh, Abdoli, Asghar, Banijamali, Razieh Sadat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113280/ https://www.ncbi.nlm.nih.gov/pubmed/32238821 http://dx.doi.org/10.1038/s41598-020-62448-3 |
Ejemplares similares
-
Kinetics of Oncolytic Reovirus T3D Replication and Growth
Pattern in Mesenchymal Stem Cells
por: Banijamali, Razieh Sadat, et al.
Publicado: (2020) -
Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens
por: Higa, Leticia H., et al.
Publicado: (2016) -
Human Papillomavirus Type16- L1 VLP Production in Insect Cells
por: Abdoli, Asghar, et al.
Publicado: (2013) -
Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines
por: Shirmohammadi, Masoumeh, et al.
Publicado: (2021) -
Reconstruction of H(3)N(2) influenza virus based virosome in-vitro
por: Abdoli, Asghar, et al.
Publicado: (2013)